CLASS I ONGOING Drug recall · Reported 27 May 2026 · FDA Enforcement Report

MG217 Multi-Symptom Treatment Cream & Skin Protectant recalled

Wisconsin Pharmacal is recalling MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), distributed nationwide in the US. The recall was initiated on 24 Apr 2026 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot #: 1024088, Exp 11/30/2026
Quantity recalled690 tubes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0553-2026
FDA event ID
98788
Recalling firm
Wisconsin Pharmacal, Jackson, WI
Classification
Class I
Status
Ongoing
Recall initiated
24 Apr 2026
FDA classified
29 May 2026
Reported
27 May 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter

Timeline

24 Apr 2026Recall initiated by company
27 May 2026Published in enforcement report+33 days
29 May 2026Classified by FDA+2 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.

Product as listed by the FDA

MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.

Where it was distributed

USA Nationwide and Bahamas

Nationwide

Questions about this recall

Why was it recalled?

Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.

Which lots are affected?

Lot #: 1024088, Exp 11/30/2026

Where was it sold?

USA Nationwide and Bahamas

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Wisconsin Pharmacal

All 3